Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 2021-05-23 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| -0.51% | +1.57% | +17.05% | -7.30% | 67.61B | |
| -5.16% | -8.63% | +38.70% | +203.59% | 51.6B | |
| +5.28% | +39.50% | +39.50% | +39.50% | 43B | |
| -2.10% | +0.89% | -49.30% | -53.47% | 40.94B | |
| +0.12% | -7.85% | +48.39% | -28.83% | 29.4B | |
| -10.83% | -14.41% | +102.94% | -44.10% | 27.09B | |
| -1.53% | -0.13% | +70.16% | +85.73% | 23.32B | |
| +3.88% | +2.16% | +11.78% | +201.51% | 19.89B | |
| -1.59% | -1.63% | +61.04% | +130.75% | 16.91B | |
| Average | -1.24% | -3.02% | +37.80% | +58.60% | 35.53B | |
| Weighted average by Cap. | -1.36% | -2.83% | +31.10% | +49.09% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.93M 2.7M 2.49M 4.73M 318M 4.8M 32.22M 12.64M 157M 12.53M 12.26M 540M | 6.18M 5.41M 4.99M 4.61M 8.75M 589M 8.89M 59.63M 23.39M 290M 23.2M 22.7M 999M |
| Net income | 1.4M 1.23M 1.13M 1.05M 1.98M 134M 2.02M 13.53M 5.31M 65.88M 5.27M 5.15M 227M | 2.41M 2.11M 1.95M 1.8M 3.41M 230M 3.47M 23.25M 9.12M 113M 9.05M 8.85M 390M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Choose MarketScreener 
